Morin hydrate alleviated cisplatin-induced testicular toxicity in rats via modulating NLRP3/NF-κB pathway
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04867-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sara Nabil Hosney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Inspection, General Administration of Pharmacists, Assiut, Egypt. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Cisplatin, Flavonoids. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minia University.
Abstract (Originalsprache)
Cisplatin (Cis) has been widely used for treating many types of solid tumors. Despite its clinical effectiveness, Cis has a considerable risk of gonadal damage that may cause infertility. Morin hydrate (MH), a natural bioflavonoid, has been known for its antioxidant and anti-inflammatory effects. Our study aimed to investigate whether pretreatment with MH could protect against Cis-induced testicular toxicity. Thirty-five adult male rats were split into five groups ( n = 7, each); control group received oral 0.5% CMC for 10 days, MH group received oral MH (100 mg/kg) for 10 days, Cis group was given a single dose of Cis (7 mg/kg, i.p) on day 5, (MH 50 + Cis) and (MH 100 + Cis) groups were pretreated with MH (50 mg/kg) and (100 mg/kg), respectively for 5 days before Cis administration, and then, treatment was continued, with either doses, for further 5 days. At the end of the study, blood and testicular tissues were collected for biochemical and histopathological studies. MH administration mitigated the testicular histopathological changes induced by Cis, increased sperm count and motility, and abrogated the abnormalities in sperm morphology. Further, MH enhanced antioxidant status and suppressed the inflammation via downregulating NF-κB and NLRP3 and inflammatory cytokines expression. Our in vitro study revealed that MH enhanced Cis-induced cytotoxicity against cancer cells, including PC3, MCF7, and HepG2. These findings suggested that MH could be applied in Cis chemotherapy regimens as a possible adjuvant therapy to enhance its effect and prevent Cis-induced testicular damage. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Inspection, General Administration of Pharmacists, Assiut, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia, Egypt. asmaa.ahmed@mu.edu.eg.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia National University (MNU), Minia, Egypt. asmaa.ahmed@mu.edu.eg.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.
- Michael Sayegh, Faculty of Pharmacy, Aqaba University of Technology, Aqaba, 77110, Jordan.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia, Egypt.
Förderung
- Minia University
Zitieren
APA
Hosney, S. N., Matouk, A. I., Ali, F. E. M., & Heeba, G. H. (2025). Morin hydrate alleviated cisplatin-induced testicular toxicity in rats via modulating NLRP3/NF-κB pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04867-5
Vancouver
Hosney SN, Matouk AI, Ali FEM, Heeba GH. Morin hydrate alleviated cisplatin-induced testicular toxicity in rats via modulating NLRP3/NF-κB pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04867-5
BibTeX
@article{Hosney2025,
author = {Hosney, Sara Nabil and Matouk, Asmaa I and Ali, Fares E M and Heeba, Gehan Hussein},
title = {Morin hydrate alleviated cisplatin-induced testicular toxicity in rats via modulating NLRP3/NF-κB pathway},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04867-5}
}
EUVIMED